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Objectives. This study was designed to examine driving safety 
in patients at risk for sudden death after implantation of a 
cardioverter-defibrillator. 
Background. Cardioverter-defibrillators are frequently im- 
planted in patients at high risk for sudden death. Despite concern 
about the safety of driving in these patients, little is known about 
their actual motor vehicle accident rates. 
Methods. Surveys were sent to all 742 physicians in the United 
States involved in cardioverter-defibrillator implantation and 
follow-up. Physicians were questioned about numbers of patients 
followed up, numbers of fatal and nonfatal accidents, physician 
recommendations to patients about driving and knowledge of 
state driving laws. 
Results. Surveys were returned by 452 physicians (61%). A total 
of 30 motor vehicle accidents related to shocks from implantable 
defibrillators were reported by 25 physicians over a 12-year period 
from 1980 to 1992. Of these, nine were fatal accidents involving 
eight patients with a defibrillator and one passenger in a car 
driven by a patient. No bystanders were fatally injured. There 
were 21 nonfatal accidents involving 15 patients, 3 passengers and 
3 bystanders. The estimated fatality rate for patients with a 
defibrillator, 7.5/100,000 patient-years, is significantly lower than 
that for the general population (18.4/100,000 patient-years, p < 
0.05). The estimated injury rate, 17.6/100,000 patient-years, is also 
significantly lower than that for the general public (2,224/100,000 
patient-years, p < 0.05). Only 10.5% (30 of 286) of all defibrillator 
discharges during driving resulted in accidents. Regarding phy- 
sician recommendations, most physicians (58.1%) ask their pa- 
tients to wait a mean (-+SD) of 7.3 -+ 3.4 months after implanta- 
tion or a shock before driving again. 
Conclusions. The motor vehicle accident rate caused by dis- 
charge from an implantable cardioverter-defibrillator is low. 
Although restricting driving for a short period of time after 
implantation may he appropriate, excessive restrictions or a total 
ban on driving appears to be unwarranted. 
(J Am Coil Cardiol 1995;26:180-4) 
Driving recommendations for patients with an implantable 
cardioverter-defibrillator (ICD) vary widely among cardiolo- 
gists, with no national consensus at the present time. Despite 
the emotionally charged iscussions that this topic may gener- 
ate, there are limited data on the risk of driving in patients with 
ICDs. There have been two surveys of physician practices 
regarding patients with ICDs (1,2), but these did not include 
data on specific outcomes in ICD patients who drive. 
It is well known that many patients with ICDs drive against 
physician advice. In a survey of ICD recipients followed up at 
the University of South Carolina, 70% of patients resumed 
driving, most by 8 months after implantation (3). Two of the 
patients reported ischarge of their ICDs while driving, but no 
accident or injury was reported. An analysis of driving hazard, 
defined as occurrence ofventricular tachycardia orfibrillation, 
syncope or defibrillator discharge, in patients with ICDs from 
one university hospital found that it was maximal in the first 
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7 months after ICD implantation and diminished substantially 
after that (4). This led to the recommendation to restrict 
driving in the first 7 months after ICD implantation. However, 
national data on actual accident rates and fatalities in patients 
with ICDs could be helpful in formulating policy. We therefore 
conducted a survey of all physicians involved in ICD implan- 
tation and follow-up in the United States to determine their 
recommendations to patients regarding driving and to collect 
information on motor vehicle accidents and fatalities in patients 
with ICDs. The results of the survey form the basis of this report. 
Methods  
All physicians involved in ICD implantation and follow-up 
were identified from a computer list provided by Cardiac 
Pacemakers, Inc. Information requested inthe survey included 
the length of time that the physician had been performing 
defibrillator implantations, the approximate otal number of 
patients followed up, recommendations made to patients re- 
garding driving, what factors physicians considered in making 
those recommendations (i.e., type of device, type and stability 
of presenting arrhythmia), knowledge of state laws about 
driving in patients with arrhythmias nd accidents and fatalities 
and injuries reported by patients and their families. To main- 
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able cardioverter-defibrillator recipients. There were 
a total of 30 fatal and nonfatal injuries reported. 
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tain confidentiality, the surveys were coded by number. If more 
than one survey was returned from one institution or practice, 
the survey of the most senior member of the group as defined 
by longer duration of time from first implantation and greater 
number of patients followed up was retained, and the other(s) 
set aside. Reports of accidents and injuries were checked by 
one of us for duplication by examining the state of origin of the 
report. If more than one accident was reported from any one 
state, the surveys were examined further for the description of 
the accident and whether two reports came from the same 
institution, with duplicates set aside. There was one duplicate 
report each of a fatality and an injury. The frequency of fatal 
and nonfatal injuries was compared with similar data from the 
U.S. Bureau of the Census. 
Some of the physicians left blanks for some of the questions, 
so that not all of the percentages presented here add up to 100%. 
Statistical analysis. Data for continuous variables are sum- 
marized and reported as mean value +_ SD. Percentages and 
rates estimated from the survey responses are reported with 
95% confidence intervals (CI) when appropriate. The chi- 
square statistic or Fisher exact test was used to compare 
response percentages between independent groups of respon- 
dents. Methods based on the Poisson distribution were used to 
compare fatality, injury and accident rates among ICD recip- 
ients with those among known population rates (5). 
Results  
Physician experience. A total of 742 surveys were mailed 
out, of which 452 (61%) were returned. Fifty surveys provided 
duplicate information for certain centers and were not ana- 
lyzed further, so that a total of 402 surveys were analyzed for 
this report. The physicians in the survey, who represented 48 
states and the District of Columbia, had been implanting ICDs 
for a mean of 5.8 _+ 2.6 years (range 1 to 12). The mean 
number of 1CD recipients followed up by each physician was 
estimated by the physicians themselves tobe 141 _+ 144 (range 
I to 1,000), or >54,000 for all respondents of the survey. At the 
time the survey was sent out (1992), ~-32,000 patients were 
known to have received ICDs in the United States (personal 
communication with U.S. ICD manufacturers). Thus, because 
61% of the surveys were returned, the physicians had clearly 
overestimated the actual number of patients with an ICD and 
follow-up data. 
Accidents among ICD recipients. Despite the large num- 
ber of ICDs implanted nationwide, very few accidents have 
been reported among ICD recipients. Fully 93.3% (374 of 401, 
95% CI 90.8% to 95.7%) of the physicians were unaware of 
any accidents among their patients. Twenty-five physicians 
reported 30 accidents; of the 25, 3 physicians reported 2 
accidents each, and 1 reported 3 accidents. Not surprisingly, 
the most experienced implanters were more likely to be aware 
of accidents involving patients with devices. For physicians 
with up to 50 1CD implantations, only 1.4% (2 of 140, 95% CI 
0.0% to 3.4%) were aware of accidents, whereas 9.4% of 
physicians with 51 to 1,000 implants (23 of 244, 95% CI 5.8% 
to 13.1%) had knowledge of accidents among patients with 
devices (p = 0.002). There were eight patient fatalities, all 
related to loss of consciousness with the device firing while the 
patient was driving. There was one fatality of a passenger in a 
vehicle driven by a patient with an ICD, but no bystanders were 
fatally injured (Fig. 1). 
To determine a driving-related fatality rate for ICD recip- 
ients, certain assumptions were necessary because of the 
overestimation of the numbers of ICD recipients by the 
responding physicians. At the time of the survey, -32,000 
patients had received ICDs in the United States. Using 1- to 
7-year survival rates for ICD recipients (all-cause mortality; 
personal communication, Cardiac Pacemakers, Inc., AICD 
Database; also ref. 6), and extrapolating 8- to ll-year survival 
rates by assuming a yearly survival rate of 95% after 7 years, 
the total number of patient-years represented by the 32,000 
ICD recipients through 1992 is -195,900. If 61% of all ICD 
recipients are assumed to be represented by the 61% of 
physicians who responded to the survey, then 119,500 patient- 
years are represented by the survey results. Nine driving- 
related fatalities among ICD recipients reported in the survey 
would thus yield a total fatality rate of 7.5/100,000 patient- 
years (95% CI 4.1/100,000 to 17.1/100,000). This rate is statis- 
tically lower than the 1989 general population driving-related 
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Figure 2. Number of patients whose implantable cardioverter- 
defibrillator fi ed while driving, as reported by each physician. 
fatality rate of 18.4/100,000 patient-years (p < 0.05) (6). If the 
results of the survey are assumed to represent all 195,900 
ICD-recipient patient-years, the driving-related fatality rate 
for this group would be even lower, 4.6/100,000 patient-years 
(95% CI 2.1/100,000 to 8.7/100,000), and would also differ 
significantly from the 1989 general population rate (p < 0.05). 
Fifteen nonfatal injuries occurred among patients with 
ICDs; in addition, three passengers and three bystanders were 
injured (Fig. 1). With 21 injuries among 19,520 patients with an 
ICD, the driving-related injury rate is 17.6/100,000 patient- 
years (95% CI 10.9/100,000 to 26.9/100,000). If the 21 reported 
injuries represented the total number for all 195,900 implant 
recipient patient-years, the injury rate would be 10.7/100,000 
patient-years (95% CI 6.6/100,000 to 16.4/100,000). In either 
case, these rates are clearly lower than the 1990 national rate 
of 2,224/100,000 patient-years (p < 0.05) (7). However, the 
proportion of all injuries that were fatal is much higher among 
ICD recipients than among the general public. The percentage 
for ICD recipients is 30% (9 of 30, 95% CI 13.6% to 46.4%), 
whereas that based on national statistics is 0.83% (18.4 of 
2,224) (p < 0.0001). 
Although the fatality and injury rates were low among ICD 
recipients, a much larger percentage of physicians reported 
that patients had their devices fire while they were driving 
without any accident or injury. Fully 30.9% of the physicians 
who responded (124 of 401, 95% CI 26.4% to 35.4%) reported 
having patients whose devices had fired while they were 
driving. Eighty-four of these physicians (67.7%, 95% CI 59.5% 
to 76.0%) reported one or two instances of ICD shock delivery 
during driving; the rest reported from 3 to 15 instances (Fig. 2). 
Because 30 fatal and nonfatal injuries were reported, only 
10.5% of ICD discharges (30 of 286 total reported firings, 95% 
CI 6.9% to 14.0%) resulted in accidents. 
Driving recommendations. Driving is permitted by 79% of 
the physicians responding tothe survey; only 20.8% (83 of 400, 
95% CI 16.8% to 24.7%) issue a blanket prohibition of driving 
to their patients. However, the majority of physicians recom- 
mend that their patients wait a variable length of time before 
resuming driving. Most physicians (58.1%, or 233 of 401, 95% 
CI 53.3% to 62.9%) ask their patients to refrain from driving 
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Figure 3. Effect of physician awareness of motor vehicle accidents 
among implantable cardioverter-defibrillator recipients on driving 
recommendations. 
until a specified length of time has passed without a shock 
(mean 7.3 _+ 3.4 months). The most common shock-free 
interval mentioned was 6 months, which was the recommen- 
dation of 66.1% of the physicians who specified a waiting 
period (154 of 233, 95% CI 60.0% to 72.2%). 
Awareness of ICD-related accidents influenced the policies 
recommended by physicians to their patients. Of the physicians 
who were aware of ICD-related driving accidents involving 
their patients, 44% (11 of 25, 95% CI 24.5% to 63.5%) advised 
their patients to refrain from driving, whereas only 19.4% of 
physicians (72 of 372, 95% CI 15.3% to 23.4%) who were 
unaware of accidents involving their patients advised against 
driving (p = 0.003) (Fig. 3). 
Physician awareness of driving laws. Physician awareness 
of the driving laws in their own states was rather poor. Only 
31.2% (125 of 401, 95% CI 26.6% to 35.7%) knew the legal 
requirements in their own states; the rest reported being 
unaware of relevant laws. Physician experience with ICDs did 
not correlate with knowledge of laws about driving (Table 1). 
Of the 125 physicians who did know their state's laws, 26 
(20.8%, 95% CI 13.7% to 27.9%) admitted to advising their 
patients contrary to those laws. 
Influence of type of device and primary event on driving 
recommendations. The nature of the patient's primary event 
influenced many physicians' willingness to recommend that 
their patients drive. Whether the patient's primary event was 
ventricular tachycardia orventricular fibrillation was important 
in decision making for 59.8% of the physicians (237 of 396, 
Table I. Physician Implantation Experience Versus Knowledge of
State Law Regarding Driving Restrictions 
Aware of State 
Driving Law 
(%) 
No. of Implantations Performed 
<50 50-10(I 100-200 >200 
Yes 30 34 32 30 
No 70 66 68 70 
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95% CI 55.0% to 64.7%), but it made no difference for 40.2% 
(159 of 396, 95% CI 35.3% to 45.0%). Low and high volume 
implanters were similarly influenced by the patient's primary 
arrhythmia. If a patient's primary rhythm disturbance was 
stable ventricular tachycardia, only three physicians (0.7%, or 
3 of 402, 95% CI 0.0% to 1.6%) thought that driving should be 
proscribed. In contrast, 64.2% of physicians (258 of 402, 95% 
CI 59.5% to 68.9%) would not allow patients to drive with 
unstable ventricular tachycardia or ventricular fibrillation. 
Twenty-five percent of physicians (99 of 402, 95% CI 20.4% to 
28.8%) would not allow driving for any of these rhythm 
disturbances. The most conservative physicians were the least 
likely to be influenced by the type of arrhythmia in advising 
their patients. Only 20.7% of those who advised against driving 
completely (17 of 82, 95% CI 12.0% to 29.5%) thought that he 
presenting arrhythmia made any difference, whereas 75.3% of 
those who advised a 6-month wait (116 of 154, 95% CI 68.5% 
to 82.1%) considered the presenting arrhythmia to be impor- 
tant (p = 0.00001). 
Only a small number of physicians (19.4%, or 78 of 402, 
95% CI 15.5% to 23.3%) thought that the newer generations 
of ICDs with memory and antitachycardia pacing would influ- 
ence their policies regarding driving. These were most likely to 
be the low volume implanters (26.2%, or 37 of 141, 95% CI 
19.0% to 33.5%); the high volume implanters were less likely 
to state that newer devices would alter their policies (11.3%, or 
39 of 344, 95% CI 8.0% to 14.7%, p = 0.001), possibly because 
they may already have had access to these devices in clinical trials. 
Discussion 
Physicians are responsible for advising their patients re- 
garding their activities after discharge from the hospital. 
Driving is a key component ofthese instructions. To develop a 
rational policy for driving for ICD recipients, data regarding 
actual event rates are important. In our survey of 742 physi- 
cians involved in ICD implantation and follow-up in the 
United States, only 30 accidents were reported over a cumu- 
lative experience of 12 years. Of these, only nine were fatal, all 
of which were patient fatalities except for one passenger. In 
addition, 21 nonfatal injuries occurred. Our survey results 
probably represent the majority of ICD recipients in the 
United States and probably most of the accidents. Physicians 
with experience to report would have been most likely to 
return the survey. The conclusion to be reached when these 
data are compared with data from the U.S. Census is that ICD 
recipients are much less likely than the general public to be 
involved in accidents resulting in serious injury, and the fatality 
rate for patients is lower than the national rate. Of course, 
there is no way to know from the results of the survey just how 
often and what distances ICD recipients drive, although we 
know from another study that most patients do resume driving 
(3). 
Larsen et al. (4) analyzed the driving hazard among 501 
patients at one university medical center and found that the 
1-year event rate (occurrence of ventricular tachycardia or 
fibrillation, syncope or defibrillator discharge) was 17%. How- 
ever, the majority of patients were treated with antiarrhythmic 
drugs, and only 8% received an ICD. Those investigators 
found that event rates were highest in the first month after 
discharge, declined to an intermediate level for months 2 to 7 
and then, at the eighth month, dropped to 0% to 1.2%/month. 
Therefore, they recommended a 7-month period of abstinence 
from driving. In the interest of keeping our survey simple to 
maximize the number of returns, we did not collect informa- 
tion as to time after implantation when the accidents occurred, 
so we cannot make any conclusions as to how many of the 
accidents would have occurred within this 7-month window. 
It should be noted that the calculations of Larsen et al. (4) 
may actually underestimate the number of shocks among ICD 
recipients because antiarrhythmic drug treatment, if effective, 
would be expected to decrease the number of episodes of 
ventricular tachycardia and fibrillation overall. Long-term ex- 
perience with the ICD has shown that 54% to 66% of patients 
receive shocks over follow-up periods ranging from 9 months 
to several years (6,8,9). The majority of these shocks are for 
documented or suspected ventricular tachycardia or fibrilla- 
tion, and the remainder are inappropriate and delivered for 
problems uch as sinus tachycardia, trial fibrillation, nonsus- 
rained ventricular tachycardia and device malfunctions. If 60% 
of ICD recipients have received shocks, then an absolute 
minimum of 19,000 shocks have occurred among all patients in 
the United States. Most patients pend comparatively ittle 
time driving, and not surprisingly, the majority of shocks do not 
occur during driving. Thus, <1% of shocks occurred uring 
driving, and of these, only 10.5% resulted in accidents. 
Development of driving policy. In developing a driving 
policy for ICD recipients, it is important to keep in mind that 
accidents related to heart disease do not occur solely in 
patients with ICDs. In one study (10) of 1,348 patients who 
died of coronary artery disease, 71 (5%) died while driving. 
Collisions related to sudden death of the driver in the pre-ICD 
era were estimated to be <6/10,000 motor vehicle accidents 
(11). If we ignore the risk in patients with a recent myocardial 
infarction or in those with congestive cardiomyopathy, and we 
proscribe driving only in patients with implantable devices, we 
could make ICDs unacceptable thera W to many patients. 
At the present time, most physicians do permit ICD recip- 
ients to drive at a mean of 7.3 _+ 3.4 months after implantation. 
These results are comparable to those of DiCarlo et al. (2), 
who surveyed 58 physicians in three states regarding their 
practices and found that 82% of the physicians recommended 
a period of abstinence of 6 _+ 3 months. Although it was a 
general consensus among the physicians in our survey that the 
hemodynamic stability of the presenting arrhythmia s impor- 
tant in decision making about driving, one other study of 
device patients does not support his approach. In that study 
(12), regardless of whether a patient's hocks had previously 
been associated with syncope, there was a 15% incidence of 
syncope with any newly occurring shocks. 
In our survey, physicians were more likely to recommend 
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abstinence from driving if they were aware of accidents among 
ICD recipients. In making recommendations to their patients, 
physicians are most likely concerned not only with patient 
safety, but with their own potential liability if accidents occur 
after they have permitted riving. However, it is important to 
remember that as we all wrestle with the problem of a rational 
policy for these patients, many patients imply do not listen to 
the recommendations of their physicians. As mentioned ear- 
lier, 70% of patients in one study (3) resumed driving by 8 
months after implantation, even though all of them had been 
advised to abstain from driving permanently. 
In view of the data regarding the very low accident rate in 
patients with ICDs, and the finding that event rates are highest 
in the first few months, a reasonable policy would be to 
recommend that patients not drive for at least 1 month and 
perhaps as long as 6 months after implantation. In addition, as 
we formulate a policy for patients with ICDs, the problem of 
inappropriate discharges must be addressed as well. It has been 
estimated that 27% to 41% of defibrillator discharges arc 
spurious (13). If inappropriate shocks from a defibrillator arc 
determined to have a correctable cause, such as supraventric- 
ular tachycardia or device malfunction, then correction of the 
problem should allow a patient o resume driving immediately 
if he or she would otherwise be able to drive. Finally, if the 
consensus i formed among physicians involved in ICD implan- 
tation and follow-up that a period of abstinence from driving is 
necessary, the recommendations are unlikely to be followed by 
patients unless tee state Department of Motor Vehicles is noti- 
fied. 
Study limitations. The results and conclusions presented in
this report must be considered within the context of certain 
limitations. The data collection was retrospective and relied on 
physician recall. It is unlikely, nor did we expect, that physi- 
cians went through their records before responding to us. This 
may explain the overestimation byresponding physicians of the 
total number of implant recipients. It is impossible to know just 
how many patients are represented by the 61% of physicians 
who responded, and so our estimates must be taken as just 
that. Although underestimation f the number of accidents, 
injuries or fatalities recalled by physicians may also have 
occurred, we think that this is much less likely due to the 
extraordinary nature of these events. We were able to elimi- 
nate some degree of overestimation of both total implant 
recipients and driving-related events by cross-referencing re- 
spondents by implantation center and considering only the 
survey responses of the most senior respondent at a given 
center as representing the implant recipients at that center. We 
further cross-referenced accident reports on an individual basis 
and excluded apparent duplicates. However, the possibility 
remains that some patients may have been counted more than 
once. 
Another limitation of our study concerns the validity of the 
estimate of total number of patient-years of ICD experience, 
which was based on all-cause mortality rates provided by 
Cardiac Pacemakers, Inc. Such validity ultimately depends on 
the completeness of mortality reporting to the company during 
the 7-year period utilized in our calculation. Early in this 
period, reporting was passive, and underreporting of ICD 
patient mortality may have occurred. Underreporting of mor- 
tality would result in an overestimation f total ICD-recipient 
patient-years. Active reporting mechanisms were eventually 
put into place during this period that would have increased the 
chances of capturing mortality events in ICD recipients. 
A final potential imitation of our survey is that we sent 
surveys only to physicians who had ever implanted efibrilla- 
tors from one company. At the time the surveys were sent out, 
these defibrillators were the only ones approved by the Food 
and Drug Administration. Although some centers were im- 
planting investigational devices, it is not likely that a center 
would have been implanting investigational devices but never a 
commercially released evice. Thus, we are confident hat the 
survey was distributed to the vast majority of physicians who 
were performing implantation at the time. 
Conclusions. The motor vehicle accident rate caused by 
discharge from an ICD is low. Although restricting driving for 
a short period of time after implantation may be appropriate, 
excessive restrictions or a total ban on driving may be unwar- 
ranted. 
Wc are indebted to Deborah L. Godwin for secretarial ssistance. 
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